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1. Introduction
Enterotoxigenic Escherichia coli (ETEC) is an impor-
tant cause of diarrhea and post-diarrheal septicemia in 
pre- and post-weaned pigs (Berberov et al., 2004). ETEC 
O8:K87, a serotype that includes some of these strains, 
is typically serum resistant, but this phenotype is lost in 
spontaneous acapsular (K87−) mutants (Stawski et al., 
1990). Strain-specifi c antibodies are known to activate 
alternative C pathway-mediated killing of serum-resis-
tant E. coli O149:K91:H10:F4ac by bovine serum, but 
their antigenic targets have not been determined (Hill 
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Abstract: Enterotoxigenic Escherichia coli (ETEC) strains that produce K88 (F4)+ fi mbria are important causes of diarrhea 
and post-diarrheal septicemia in swine. ETEC O8:K87, a serotype represented by a number of these strains, is typically se-
rum resistant. Strain-specifi c antibodies are known to activate alternative C pathway-mediated killing of other serum-resis-
tant E. coli [Hill, A.W., Shears, A.L., Hibbitt, K.G., 1978. The requirement of specifi c antibody for the killing of E. coli by 
the alternate complement pathway in bovine serum. Immunology 34, 131–136], but their antigenic targets have not been 
determined. We tested the hypothesis that anti-K87 antibodies activate alternative pathway-mediated killing of ETEC O8:
K87. Pigs were immunized with ETEC O8:K87 strain 2534-86 cells or purifi ed K87 polysaccharide. Post-, but not pre-im-
munization sera killed 2534-86 cells, and absorption with 2534-86 cells or by K87 affi nity chromatography eliminated bac-
tericidal activity. Complementation of absorbed serum with anti-K87 antibodies restored bactericidal activity, confi rming 
the ability of these antibodies to activate C-mediated serum killing. Serum from age-matched, non-vaccinated control pigs 
also killed 2534-86. This activity was eliminated by absorption with 2534-86 cells, but not K87 affi nity chromatography, 
indicating that specifi c non-capsular antibodies are also able to activate C-mediated killing. In all cases, Mg-EGTA-treated 
serum was as effective as non-treated serum in killing, suggesting that bactericidal activity was mediated predominantly if 
not exclusively via the alternative C pathway. 
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et al., 1978). In the present study, we hypothesized that 
anti-K87 antibodies activate alternative C pathway-me-
diated killing of ETEC O8:K87 in porcine serum and re-
moval of these specifi c antibodies mitigates this activity. 
We provide evidence herein supporting this hypothesis; 
we also found that these antibodies are highly prevalent 
in the swine population, and that specifi c non-capsular 
antibodies also activate alternative pathway-mediated 
killing.
2. Materials and methods
2.1. Bacterial strains
Strain 2534-86 (ETEC; O8:K87:NM:F4ac) was origi-
nally isolated from a piglet with diarrhea and septicemia, 
and causes these clinical manifestations in gnotobiotic 
piglets (Berberov et al., 2004). This strain was used to 
immunize animals against E. coli cells expressing K87 
capsular polysaccharide, and was a source of the latter 
for purifi ed antigen. E. coli O8:K− strain F1321 (Meier 
and Mayer, 1985) and E. coli strain K12:F4ac (Berberov 
et al., 2004) were used to test the specifi city of the indi-
rect ELISA for K87 antibodies. E. coli strain DH5α was 
used as a positive control to test for C-mediated bacteri-
cidal activity of serum.
2.2. Isolation and purifi cation of K87 capsular poly-
saccharide antigen
Purifi ed K87 capsular polysaccharide (PP) was isolated 
by phenol–water extraction (Jann, 1985) from strain 
2534-86 cultures. Glucose concentration (Saha and 
Brewer, 1994) was 95.46% of the calculated yield per 
gram, suggesting that the extract was K87 polysaccha-
ride. No evidence of protein, LPS or nucleic acid con-
tamination was found; purity was confi rmed by 1H nu-
clear magnetic resonance spectroscopy (1H NMR) of the 
extract conducted in D2O. Chemical shifts and coupling 
patterns were identical to the K87 spectrum reported by 
Parolis et al. (1990).
2.3. 1H NMR studies
1H NMR spectroscopy was conducted on a Varian 
Unity 500 MHz spectrometer at 25 °C. A presatura-
tion sequence was utilized to reduce the intensity of 
the H2O peak which served as an internal standard at 
δ 4.773. 1H NMR (δ, ppm, D2O) 1.307 (Mc), 1.972, 
1990, 2.083 (CH3CO), 3.20–3.30, 3.42–3.58, 3.60–
4.05, 4.10–4.20, 4.35–4.58, 4.62–4.75, 4.80–4.90, 
5.15–5.21, 5.43–5.52.
2.4. Preparation of formalin-treated strain 2534-86 
cells for immunization
Formalinized E. coli strain 2534-86 cells for immuni-
zation were prepared using the methods of Gross and 
Rowe (1985). Bacteria were washed twice by centrifu-
gation and resuspension in 0.9% saline, and resuspended 
in 0.3% (v/v) solution of commercial 10% neutral-buff-
ered formalin in 0.9% saline at a concentration equiva-
lent to 1.0 × 109 CFU/ml.
2.5. Experimental animals
BALB/c mice (6–8-week-old adult females; n = 16), 
specifi c pathogen-free (SPF) New Zealand White rab-
bits (5–6 month-old adult females; n = 2), and cesar-
ean-derived, colostrum-deprived, primary SPF pure-
bred Yorkshire pigs (n = 10) were immunized against 
PP or 2534-86 cells. When pigs were 1 month old, 
seven were used for immunization, and three were non-
vaccinated and kept in the same room as controls. Se-
rum samples were obtained prior to the fi rst immuniza-
tion and at the conclusion of immunizations, at which 
time they were euthanatized and exsanguinated. Se-
rum samples from 75 conventional pigs from 11 herds 
in fi ve different counties in Nebraska were obtained to 
test for antibodies to K87; 40 pigs were 8 weeks old 
and 35 were 5–6 months old. Serum samples were 
stored at −70 °C until used in assays. Animal experi-
ments were approved by the UNL Institutional Animal 
Care and Use Committee.
2.6. Immunization protocols
Immunization protocols for PP and 2534-86 cells were 
developed by modifi cation of standard procedures. Mice 
(n = 8) were primed i.p. with 100 μg PP and 100 μl 
complete Freund’s adjuvant (CFA), and boosted twice 
i.p. with 50 μg PP and 50 μl incomplete Freund’s adju-
vant (IFA), or (n = 8) primed i.p. with 1.0 × 108 CFU 
and 100 μl CFA, and boosted twice i.p. with 1.0 × 108 
CFU and 50 μl IFA. Rabbits (n = 1) were primed s.c. 
with 150 μg PP and 150 μl CFA, and boosted twice 
s.c. with 75 μg PP and 75 μl IFA, or (n = 1) primed i.v. 
with 0.5 × 109 CFU, and boosted four times i.v. with 
1.0–2.0 × 109 CFU. Pigs (n = 4) were primed s.c. with 
200 μg PP and 200 μl CFA, and boosted twice s.c. with 
100 μg PP and 100 μl IFA, or (n = 3) primed i.v. with 
0.5 × 109 CFU, and boosted twice i.v. with 0.5 × 109 
CFU. Cells used for the fi rst dose given to the pigs were 
inadvertently boiled, although the remaining doses were 
not.
ANTI-CAPSULAR ANTIBODIES ACTIVATE KILLING OF ESCHERICHIA COLI O8:K87 187
2.7. Indirect enzyme-linked immunosorbent assay 
(ELISA) to detect anti-K87 antibodies
An indirect ELISA was developed using standard pro-
cedures to measure the titers of anti-K87 antibodies in 
sera. Polystyrene 96-well plates were coated with anti-
gen, each well with 50 μl of a PBS solution containing 
10 ng PP. Sera were diluted from 1:100 to 1:204,800 in 
wells of the plates. Goat anti-species IgG labeled with 
horseradish peroxidase was used as the secondary anti-
body, with peroxide and o-phenylenediamine for color 
development. Absorption was measured at 490 nm. The 
antibody titer was the highest dilution having an absor-
bance (mean ± 1 S.E.M.) greater than the negative con-
trol (mean ± 1 S.E.M.).
2.8. Absorption of specifi c antibodies from serum
Antibodies to K87 and other surface antigens on E. 
coli strains were absorbed from sera with bacteria us-
Figure 1. (A) Indirect ELISA for detection of anti-K87 antibodies. Serum from rabbit immunized with formalin-treated E. coli O8:K87 strain 
2534-86 cells. Purifi ed K87 polysaccharide (PP) was coated onto polyvinyl chloride microtiter plate wells, and serum dilutions from immu-
nized animals were added. Binding of antibodies to the immobilized polysaccharide was detected by goat anti-species IgG labeled with horse-
radish peroxidase, and o-phenylenediamine substrate, and reactions were read at 490 nm. The specifi city of the assay for anti-K87 antibodies 
was validated by absorption with cells expressing F4ac fi mbria, O8 antigen and other surface antigens commonly found on E. coli O8 bacteria. 
(B) Serum from primary SPF pigs immunized with formalinized 2534-86 cells and absorbed with 2534-86 or E. coli O8:K− strain F1321 cells. 
(C) Serum from primary SPF pigs immunized with PP and absorbed with 2534-86 or F1321 cells. 
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ing standard procedures (Gross and Rowe, 1985), or 
by affi nity chromatography using epoxy-activated Sep-
harose 6B beads (Amersham Pharmacia Biotech) cou-
pled to PP. PP was added at a concentration of 400 μg/
ml and using a gel:buffer ratio of 1:2. Absorption con-
trol sera were prepared with a column containing Sep-
harose 6B beads not coupled to PP. Sera were passed 
through the column and absorbed antibodies were 
eluted with 0.1 M sodium citrate (pH 3.0). Two hun-
dred microliters eluate fractions were collected and the 
pH adjusted to 7.5 with 1 M Tris–HCL (pH 9.0). Frac-
tions containing protein (bicinchoninic assay) were 
added to absorbed sera. All sera to which eluate was 
not added were diluted with an equal volume of buffer, 
and adjusted to pH 7.3 in order to standardize test and 
control samples.
2.9. Serum bactericidal assay
Serum bactericidal assays were performed with pre- and 
post-immunization sera of primary SPF pigs immunized 
with PP or strain 2534-86 cells, and control pigs. Assays 
were performed with serum that was untreated, treated 
with MgCl2 and ethylene glycol tetraacetic acid (Mg-
EGTA), and heat-inactivated (56 °C for 30 min; Burns 
and Hull, 1998). Buffered saline gelatin (BSG) with 
Mg2+ (10 or 20 mM MgCl2) and EGTA (10 or 20 mM) 
was added to serum.
3. Results and discussion
The indirect ELISA to detect anti-K87 antibodies was 
validated by absorption of serum from a rabbit immu-
nized with 2534-86 cells using E. coli cells exposing O8, 
F4ac fi mbria, and other surface antigens (Figure 1A). No 
reduction in titer occurred following absorption of post-
immunization serum with formalinized strain F1321 
(O8:K−) cells exposing O8 and other E. coli surface an-
tigens or boiled cells exposing O8 antigen, or following 
absorption with formalinized K12:F4ac cells exposing 
F4ac fi mbriae. However, absorption with formalinized 
2534-86 cells exposing K87 antigen eliminated the ti-
ters. Immunization of mice with 2534-86 cells or PP 
caused seroconversion (data not shown). All conven-
tional pigs tested were positive for antibodies to K87, 
with titers ranging from 1:6400 to 1:204,800. Immuni-
zation of colostrum-deprived, primary SPF pigs with 
2534-86 cells and PP caused seroconversion to K87 an-
tigen (Figure 1B and C, respectively), whereas non-vac-
cinated age-matched (68–72-day-old) control pigs were 
seronegative (data not shown). Absorption of post-im-
Figure 2. Indirect ELISA for detection of anti-K87 antibodies. (A) Serum from primary SPF pig immunized with formalin-treated strain 2534-
86 cells. Serum was subjected to 2–3 cycles of affi nity chromatography with Sepharose 6B beads coupled to K87 polysaccharide (PP), or Sep-
harose beads not coupled to PP. (B) Serum from primary SPF pig immunized with PP. Serum was subjected to 2–3 cycles of affi nity chroma-
tography with beads coupled or not to PP. 
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munization pig sera with formalinized 2534-86 cells but 
not F1321 (O8:K−) cells eliminated the anti-K87 titers 
(data not shown). K87 affi nity chromatography caused 
complete removal of detectable anti-K87 antibodies in 
sera from primary SPF pigs immunized with 2534-86 
cells (Figure 2A) and PP (Figure 2B), whereas absorp-
tion control sera retained these antibodies. 
To address whether anti-K87 antibodies specifi cally 
activate C-mediated bactericidal activity, sera from pri-
mary SPF pigs immunized with formalinized 2534-86 
cells or PP were tested in bactericidal assays against 
2534-86 cells. Pre-immunization sera had no bactericidal 
activity after 3 h incubation, whereas sera from pigs im-
munized with formalinized 2534-86 cells or PP elicited 
Figure 3. Bactericidal assay with antiserum from primary SPF pigs immunized with formalinized E. coli O8:K87 strain 2534-86 cells (n = 3) or 
purifi ed K87 polysaccharide (K87, n = 4). (A) Untreated serum; (B) Mg-EGTA-treated serum; (C) heat-inactivated serum. Pre-immunization: 
mean values of all pigs combined prior to immunization, anti-2534: serum from pigs immunized with 2534-86 cells, anti-K87: serum from pigs 
immunized with K87, abs-2534: serum from pigs immunized with 2534-86 cells and absorbed with 2534-86 cells, abs-K87: serum from pigs 
immunized with K87 and absorbed with 2534-86 cells, affi n-2534: serum from pigs immunized with 2534-86 cells and absorbed by affi nity 
chromatography with beads coupled to K87, affi n-K87: serum from pigs immunized with K87 and absorbed by affi nity chromatography with 
beads coupled to K87, affi n-2534AB: serum from pigs immunized with 2534-86 cells, absorbed by affi nity chromatography with beads coupled 
to K87, and eluted anti-K87 antibodies from column added back to serum and affi n-K87AB: serum from pigs immunized with K87, absorbed 
by affi nity chromatography with beads coupled to K87, and eluted anti-K87 antibodies from column added back to serum. 
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>99% killing after 2 h incubation (Figure 3). The bacte-
ricidal activity of Mg-EGTA-treated sera in both groups 
was equivalent to that of untreated serum. These results 
suggested that killing activity occurred predominantly, 
if not exclusively by the alternative C pathway since 
EGTA chelates Ca2+, inactivating the classical C path-
way, but has a lower affi nity for Mg2+; the addition of 
Mg2+ allows the alternative pathway to proceed (Burns 
and Hull, 1998). Absorption of sera with 2534-86 cells 
completely removed bactericidal activity (Figure 3), 
whereas absorption of the same sera with formalinized 
strain F1321 (E. coli O8:K−) cells had no apparent ef-
fect (data not shown). Hence, specifi c antibodies are 
needed for bactericidal activity against E. coli O8:K87. 
Sera from primary SPF pigs immunized with purifi ed PP 
retained bactericidal activity against E. coli DH5α fol-
lowing absorption with formalinized 2534-86 cells (data 
not shown), which confi rmed that the absorption pro-
cess had not eliminated the C-mediated bactericidal ac-
tivity against serum-sensitive bacteria. Absorption by 
K87 affi nity chromatography eliminated bactericidal ac-
tivity, whereas absorption control sera from these same 
pigs had retained activity (Figure 3). Untreated and Mg-
EGTA-treated absorbed sera from pigs immunized with 
either PP or 2534-86 cells complemented with eluted 
anti-K87 antibodies had restoration of killing activity 
(Figure 3). The anti-K87 titers of pre-absorbed serum 
and complemented serum were comparable (data not 
shown). Restoration of bactericidal activity in comple-
mented serum confi rmed the ability of anti-K87 antibod-
ies to activate C-mediated killing. 
To determine whether antibodies other than anti-
K87 could activate killing of 2534-86, bactericidal as-
says were conducted with serum from primary SPF age-
matched (68–72-day-old) control pigs lacking anti-K87 
antibodies. This serum effected >99% killing by 3 h in-
cubation, and bactericidal activity of Mg-EGTA-treated 
serum was equivalent to that of untreated serum. The 
killing activity of age-matched control pig serum was 
eliminated by absorption with 2534-86 cells; however, 
it was not eliminated by K87 affi nity chromatography 
(data not shown). These results indicated that specifi c 
antibodies other than anti-K87 can activate killing, al-
though the antigen against which these non-capsular an-
tibodies were directed was not addressed.
Since Mg2+ and Ca2+ are needed for the alterna-
tive and classical C pathways, respectively, to proceed, 
their concentrations in absorbed and non-absorbed sera 
from two primary SPF pigs tested in the bactericidal 
assays were determined. The Mg2+ and Ca2+ concen-
trations of non-absorbed sera of both pigs were within 
the normal range for porcine serum; however, concen-
trations of both cations in one of these sera after affi n-
ity chromatography were below the normal range. Ad-
dition of MgCl2 restored its bactericidal activity when 
complemented with eluted antibodies. By contrast, the 
Mg2+ and Ca2+ concentrations of the serum of the sec-
ond pig, absorbed at a higher fl ow rate (4 ml/min), 
were within the normal range, indicating that the loss 
of bactericidal activity in affi nity chromatography-ab-
sorbed serum was not due to an alteration in the con-
centration of these cations.
The ability of anti-capsular antibodies to activate al-
ternative pathway killing of E. coli O8:K87 extends the 
observations reported by Hill et al. (1978). In that study, 
strain-specifi c antibodies activated alternative pathway 
killing of E. coli; however, bovine serum and a different 
serotype of E. coli were used, and the antigenic target 
was not identifi ed. Interestingly, strains of the serotype 
used in that study (O149:K91) are typically enterotoxi-
genic, express F4 fi mbria and are only known to cause 
natural disease in swine (Morris and Sojka, 1985). Sim-
ilarly, anti-capsular antibodies, specifi cally of the IgG 
class, kill Haemophilus infl uenzae type B (Hib), in a pro-
cess that occurs exclusively by the alternative pathway 
(Tarr et al., 1982); however, non-capsular antibodies are 
capable of C activation and killing of Hib, but this oc-
curs exclusively by the classical pathway (Steele et al., 
1984). Collectively, these studies suggest that alternative 
C pathway activation by anti-capsular antibodies may 
represent a common defense mechanism in mammalian 
species against encapsulated, serum-resistant Gram-neg-
ative bacteria. In the case of swine, anti-K87 antibod-
ies appear to be highly prevalent, and we deduce that 
they may play an important role in host defense against 
ETEC-mediated post-diarrheal septicemia. 
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